Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

      True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

      Medical Dialogues Bureau21 Oct 2018 12:01 PM IST
      Mumbai: Merck Consumer Health India - a leader in Vitamin E in India - announced the publication of the country’s first handbook that highlights the...
      Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

      Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

      Medical Dialogues Bureau21 Oct 2018 11:01 AM IST
      New Delhi: Jubilant Cadista Pharmaceuticals Inc, is recalling over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets manufactured by...
      FDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacks

      FDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacks

      Medical Dialogues Bureau21 Oct 2018 10:01 AM IST
      In trials for heart disease, Novartis discovered a potential benefit in lung cancer patients for the drug, prompting the company to start cancer...
      Takeda gets Japans approval for $62 billion Shire purchase

      Takeda gets Japan's approval for $62 billion Shire purchase

      Medical Dialogues Bureau21 Oct 2018 9:27 AM IST
      Takeda Pharmaceutical Co Ltd. said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the...
      Shires drug Takhzyro for rare swelling disorder wins European panel green light

      Shire's drug Takhzyro for rare swelling disorder wins European panel green light

      Medical Dialogues Bureau21 Oct 2018 9:01 AM IST
      A European Medicines Agency(EMA) panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older...
      Dengue vaccine should be approved: European Medicines Agency

      Dengue vaccine should be approved: European Medicines Agency

      Medical Dialogues Bureau20 Oct 2018 3:03 PM IST
      LONDON - Europe's medicines regulator has recommended the approval of the first vaccine for dengue despite concerns about the vaccine's wide use and a...
      Sanofi drug Dupixent wins USFDA approval to treat asthma

      Sanofi drug Dupixent wins USFDA approval to treat asthma

      Medical Dialogues Bureau20 Oct 2018 12:32 PM IST
      France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in...
      Maryland asks Supreme Court to uphold law on drug pricing

      Maryland asks Supreme Court to uphold law on drug pricing

      Medical Dialogues Bureau20 Oct 2018 12:32 PM IST
      ANNAPOLIS, Md.: Maryland Attorney General Brian Frosh petitioned the U.S. Supreme Court on Friday to uphold a first-in-the-nation law against...
      Zydus Cadila gets USFDA nod for generic gout attacks drug- Colchicine

      Zydus Cadila gets USFDA nod for generic gout attacks drug- Colchicine

      Medical Dialogues Bureau20 Oct 2018 12:30 PM IST
      The tablets, "will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad," it said.New Delhi: Drug firm Zydus Cadila...
      Novartis to buy cancer drugmaker Endocyte for $2.1 Billion in cash

      Novartis to buy cancer drugmaker Endocyte for $2.1 Billion in cash

      Medical Dialogues Bureau20 Oct 2018 9:18 AM IST
      Novartis AG will acquire U.S. based cancer drugmaker Endocyte Inc for $2.1 billion in cash as the Swiss drugmaker expands its radio pharmaceuticals...
      Trivitron launches 4 novel Newborn Screening panels, Check out details

      Trivitron launches 4 novel Newborn Screening panels, Check out details

      Medical Dialogues Bureau19 Oct 2018 1:21 PM IST
      Bratislava, Slovakia: Trivitron’s Labsystems Diagnostics Oy, a leading brand that develops and manufactures high quality diagnostic tests for clinical...
      Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatment

      Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatment

      Medical Dialogues Bureau19 Oct 2018 10:51 AM IST
      New Delhi: Drug firm Zydus Cadila Wednesday said it has received final nod from the US health regulator to market generic Clobetasol Propionate cream,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok